MAM
KZR

Marquette Asset Management’s Kezar Life Sciences KZR Stock Holding History

Marquette Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,805
Closed -$120K – 180
2024
Q4 		$120K Sell
17,805
-1
-0% -$7 0.02% 117
2024
Q3 		$138K Hold
17,806
– – 0.02% 116
2024
Q2 		$107K Buy
17,806
+5,196
+41% +$39.5K 0.02% 104
2024
Q1 		$114K Buy
+12,610
New +$115K 0.02% 109

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Marquette Asset Management's KZR Position: Q1 2025 in Review

Marquette Asset Management sold out of Kezar Life Sciences (KZR) in Q1 2025, closing a stake of 17,805 shares — an estimated $120K sold.

Marquette Asset Management first reported a position in KZR in Q1 2024 and held it in 4 quarters. The position peaked at $138K in Q3 2024. 41 funds tracked by Wall St. Rank hold KZR as of Q1 2025.

  • Marquette Asset Management reported no remaining Kezar Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 17,805 Kezar Life Sciences shares in Q1 2025, an estimated $120K.
  • Marquette Asset Management first reported a position in Kezar Life Sciences in Q1 2024 and held it in 4 quarters.
  • Marquette Asset Management's Kezar Life Sciences position peaked at $138K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.